Evidence map›Paper›PMID 35581521›Full record

ArticleMolecular neurobiology2022

Effect of TDP43-CTFs35 on Brain Endothelial Cell Functions in Cerebral Ischemic Injury.

Xiaotian Xu, Changwen Zhang, Jianxiong Jiang, Mei Xin, Jiukuan Hao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Total Flavones ofCurrent issues in molecular biology · 2025
    Article
  5. Article
  6. Article
  7. Acute severe hypoglycemia alters mouse brain microvascular proteome.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  8. Establishment of a novel amyotrophic lateral sclerosis patient (Frontiers in cell and developmental biology · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xiaotian XuDepartment of Neurology, The Affiliated Hospital of Yangzhou University, Jiangsu Province, Yangzhou, 225000, China.
Changwen ZhangCincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Jianxiong JiangDepartment of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, TN, 38163, USA.
Mei XinDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 45229, USA.
Jiukuan HaoDepartment of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204-5000, USA. jhao6@central.uh.edu.ORCID http://orcid.org/0000-0001-6629-5575
Cincinnati Children's Hospital Medical Center · USUniversity of Houston · USUniversity of Tennessee Health Science Center · US

Funding

Targeting the Hippo signaling at the Blood-brain barrier for therapy of ischemic strokeR01NS105787 · NINDS · UNIVERSITY OF HOUSTON · PI HAO, JIUKUAN · 2018 to 2023
$1.7M
National Natural Science Foundation of China 81901084NINDS NIH HHS R01 NS105787NINDS NIH HHS R01NS105787
6 · The paper itself

Abstract

Pathological changes in the brain endothelium play an important role in the progression of ischemic stroke and the compromised BBB under ischemic stroke conditions cause neuronal damage. However, the pathophysiological mechanisms of the BBB under normal conditions and under ischemic stroke conditions have not been fully elucidated. The present study demonstrated that knockdown of TAR DNA-binding protein 43 (TDP-43) or overexpression of TDP43-CTFs35 inhibited tight junction protein expression, and mammalian sterile-20-like 1/2 (MST1/2) and YES-associated protein (YAP) phosphorylation in brain ECs and suppressed brain EC migration in vitro. The cytoplasmic TDP43-CTFs35 level was increased in brain ECs 24 h and 72 h after MCAO, but it disappeared 1 week after cerebral ischemia. The expression of tight junction proteins was also significantly deceased 24 h after MCAO and then gradually recovered at 72 h and 1 week after MCAO. The level of YAP phosphorylation was first significantly decreased 24 h after MCAO and then increased 72 h and 1 week after MCAO, accompanied by nuclear YAP translocation. The underlying mechanism is TDP43-CTFs35-mediated inhibition of Hippo signaling pathway activity through the dephosphorylation of MST1/2, which leads to the inhibition of YAP phosphorylation and the subsequent impairment of brain EC migration and tight junction protein expression. This study provides new insights into the mechanisms of brain vascular EC regulation, which may impact on BBB integrity after cerebral ischemic injury.

Indexed as

Brain InjuriesBrain IschemiaIschemic StrokeAnimalsBlood-Brain BarrierBrainDNA-Binding ProteinsEndothelial CellsEndotheliumInfarction, Middle Cerebral ArteryMammalsTight Junction ProteinsDNA-Binding ProteinsTight Junction ProteinsBBBEndothelial cellHippo signaling pathwayMCAOTDP43TDP43-CTFs35

Identifiers

PMID35581521
OpenAlexW4280497305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.